National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

iodine I 131 tositumomab
A monoclonal antibody directed against the CD20 protein expressed on the surface of B-lymphocytes and radiolabeled with the radioisotope iodine I 131 with potential antineoplastic activity. Iodine I 131 tositumomab binds to and selectively delivers cyctotoxic radiation to CD20-expressing B-lymphocytes, thereby minimizing systemic radiotoxicity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:131-I-anti-B1 antibody
131-I-anti-B1 monoclonal antibody
iodine I 131 MOAB anti-B1
iodine I 131 monoclonal antibody anti-B1
iodine-131 anti-B1 antibody
iodine-131 anti-CD20 monoclonal antibody
Abbreviation:I131-MOAB-B1



Previous:iodine I 131 monoclonal antibody 3F8, iodine I 131 monoclonal antibody 81C6, iodine I 131 monoclonal antibody 8H9, iodine I 131 monoclonal antibody BC8, iodine I 131 monoclonal antibody CC49-deltaCH2
Next:iodine-123 metaiodobenzylguanidine, Iodotope, ipilimumab, ipomeanol, iproplatin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov